In November 2019, DNA Script opened its first American office in California, in South San Francisco.
This first office in the United States is part of our preparation for the commercialization of SYNTAXTM scheduled for mid-2021!
In November 2019, DNA Script opened its first American office in California, in South San Francisco.
This first office in the United States is part of our preparation for the commercialization of SYNTAXTM scheduled for mid-2021!
As famous and mythic, San Francisco will not disappoint you! There is something for every tastes there: festivals, operas, theaters, museums, artists... and the famous Golden Gate. San Francisco is known for being a city full of ideas, invention and imagination. It's no coincidence that Silicon Valley is located there, being a concentration of inventiveness that DNA Script intends to draw inspiration from to establish itself there permanently.
And good news, we also offer the possibility to pursue a VIE there!
Opening
People
DNA Script is a leading company in manufacturing de novo synthetic nucleic acids using enzymatic DNA synthesis (EDS) technology. The company aims at accelerating innovation in life science and technology through the decentralization of rapid, on demand and high-quality DNA synthesis. DNA Script's approach leverages nature's billions of years of evolution in synthesizing DNA to set a new standard for customizing nucleic acid synthesis thus accelerating discovery in genetics, genomics, and synthetic biology. Discovery disciplines with profound impacts upon humanity such as biopharma, translational genetics and even molecular information storage all start with synthetic DNA. The company has recently initiated the commercialization of its first EDS powered platform, the SYNTAX system.
To date, DNA Script has raised over $315M of financing, with leading investors such as Coatue Management, Fidelity Management and Research, Catalio Capital Management, Casdin Capital, LSP, Bpifrance Large Ventures, Danaher, Illumina Ventures, Agilent, Merck Ventures, Sofinnova Partners, Kurma Partners and Eurazeo.
DNA Script also partners on technology and product development with leading organizations such as DARPA, IARPA, Moderna Therapeutics, GE Research, Illumina, the Broad Institute, Harvard University, Institut Pasteur and the French Department of Defense.
DNA Script has its research and manufacturing facilities headquartered in Paris, France, and is in the process of expanding its commercial and development teams in South San Francisco.
They’re above all science-driven thinkers, makers, dreamers and do-ers.
DNA Script is now moving to a new stage of development, i.e. commercialization. That’s why they are looking for new talents in different fields: R&D, manufacturing and supply chain, sales and marketing, industrial and IT engineering, quality, customer service, etc.
Are you passionate about life sciences, curious, motivated, proactive and you want to invest in a company with an innovative project? Do not hesitate to send them your application!
Join DNA Script means :